• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

温度对磺胺类药物与碳酸酐酶同工酶I、II和IV结合的影响。

The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV.

作者信息

Conroy C W, Maren T H

机构信息

University of Florida College of Medicine, Department of Pharmacology and Therapeutics, Gainesville 32610, USA.

出版信息

Mol Pharmacol. 1995 Sep;48(3):486-91.

PMID:7565629
Abstract

We report the effect of temperature on the equilibrium dissociation constants (Kl) for a series of six sulfonamides binding to three carbonic anhydrase (CA) isoenzymes (I, II, and IV). Kl values obtained at 0 degree, 15 degrees, and 23 degrees under conditions of nearly constant and low substrate (CO2) concentration were used to calculate enthalpy and entropy changes associated with sulfonamide binding as well as to provide estimates of inhibitory potency of sulfonamides at 37 degrees. We studies four classic sulfonamide (methazolamide, benzolamide, ethoxzolamide, and sulfanilamide) and the novel sulfonamides MK-507 (dorzolamide) and CF3SO2NH2. In all cases, the Kl was observed to increase with increasing temperature, which is consistent with a negative enthalpy of sulfonamide binding. The extrapolated increase in Kl over the 0-37 degrees temperature range varied from 4-fold for sulfanilamide binding to CA l to 14-fold for CF3SO2NH2 binding to CA IV, corresponding to binding enthalpy values of -7.2 to -11.7 kcal/mol. For CA II and I, entropy changes associated with sulfonamide binding were in general modest and ranged from -5.3 to +4.1 entropy units (eu) for five of the compounds tested. In contrast, ethoxzolamide binding was associated with a relatively large positive entropy change. Also, the variatione in k(on) and k(off) with temperature were studied for three sulfonamides binding to CA II. The association rate constants for methazolamide, benzolamide, and ethoxzolamide binding showed increases of 2-fold or less, whereas dissociation constants increased 3-9-fold over the range of 0-37 degrees. Thus, the temperature effect in increasing Kl is in large part due to a faster rate of sulfonamide dissociation. Apparent activation parameters at 23 degrees for k(on) were delta H++ = -2.35 to 3.8 kcal/mol, delta G++ = 7.3 to 8.6 kcal/mol, and delta S++ = -16.2 to -32.7 entropy units. For k(off), the corresponding values were delta H++ = 5.6 to 14.5 kcal/mol, delta G++ = 19.0 kcal/mol, and delta S++ = -14.8 to -45.7 entropy units.

摘要

我们报告了温度对一系列六种磺胺类药物与三种碳酸酐酶(CA)同工酶(I、II和IV)结合的平衡解离常数(Kl)的影响。在底物(CO2)浓度近乎恒定且较低的条件下,于0℃、15℃和23℃获得的Kl值用于计算与磺胺类药物结合相关的焓变和熵变,以及估算磺胺类药物在37℃时的抑制效力。我们研究了四种经典磺胺类药物(甲醋唑胺、苯甲酰胺、乙氧唑胺和磺胺)以及新型磺胺类药物MK - 507(多佐胺)和CF3SO2NH2。在所有情况下,均观察到Kl随温度升高而增加,这与磺胺类药物结合的负焓变一致。在0 - 37℃温度范围内,Kl的外推增加倍数从磺胺与CA I结合的4倍到CF3SO2NH2与CA IV结合的14倍不等,对应结合焓值为 - 7.2至 - 11.7千卡/摩尔。对于CA II和I,测试的五种化合物中,与磺胺类药物结合相关的熵变通常较小,范围为 - 5.3至 + 4.1熵单位(eu)。相比之下,乙氧唑胺的结合与相对较大的正熵变相关。此外,还研究了三种磺胺类药物与CA II结合时k(on)和k(off)随温度的变化。甲醋唑胺、苯甲酰胺和乙氧唑胺结合的缔合速率常数增加2倍或更少,而解离常数在0 - 37℃范围内增加3 - 9倍。因此,Kl增加的温度效应在很大程度上是由于磺胺类药物解离速率加快。23℃时k(on)的表观活化参数为ΔH++ = - 2.35至3.8千卡/摩尔,ΔG++ = 7.3至8.6千卡/摩尔,ΔS++ = - 16.2至 - 32.7熵单位。对于k(off),相应的值为ΔH++ = 5.6至14.5千卡/摩尔,ΔG++ = 19.0千卡/摩尔,ΔS++ = - 14.8至 - 45.7熵单位。

相似文献

1
The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV.温度对磺胺类药物与碳酸酐酶同工酶I、II和IV结合的影响。
Mol Pharmacol. 1995 Sep;48(3):486-91.
2
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.碳酸酐酶抑制剂。用芳香族和杂环磺酰胺抑制人胞质同工酶VII。
Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6. doi: 10.1016/j.bmcl.2004.12.052.
3
Catalysis and inhibition of human carbonic anhydrase IV.人碳酸酐酶IV的催化与抑制作用
Biochemistry. 1997 Mar 4;36(9):2669-78. doi: 10.1021/bi962663s.
4
Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.碳酸酐酶抑制剂。用磺胺类药物抑制膜结合的人及牛同工酶IV。
Bioorg Med Chem Lett. 2005 Feb 15;15(4):1149-54. doi: 10.1016/j.bmcl.2004.12.009.
5
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.碳酸酐酶抑制剂。人分泌型同工酶VI的DNA克隆、特性鉴定及抑制研究,磺胺类和氨基磺酸盐抑制剂的新靶点
J Med Chem. 2007 Jan 25;50(2):381-8. doi: 10.1021/jm0612057.
6
Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.碳酸酐酶抑制剂:幽门螺杆菌羧基末端截短的α-碳酸酐酶的克隆及磺胺类抑制研究
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2182-8. doi: 10.1016/j.bmcl.2006.01.044. Epub 2006 Feb 3.
7
Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.碳酸酐酶抑制剂。磺胺类药物对一种珊瑚分泌亚型的抑制研究。
Bioorg Med Chem. 2009 Jul 15;17(14):5054-8. doi: 10.1016/j.bmc.2009.05.063. Epub 2009 May 30.
8
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.S-糖基伯磺酰胺——一类用于选择性抑制癌症相关碳酸酐酶的新型结构化合物。
J Med Chem. 2009 Oct 22;52(20):6421-32. doi: 10.1021/jm900914e.
9
Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.碳酸酐酶抑制剂。用磺胺类药物抑制古细菌的原核β类和γ类酶。
Bioorg Med Chem Lett. 2004 Dec 20;14(24):6001-6. doi: 10.1016/j.bmcl.2004.09.085.
10
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.碳酸酐酶抑制剂。结核分枝杆菌一种新型β-碳酸酐酶的克隆、表征及抑制研究。
J Med Chem. 2009 May 14;52(9):3116-20. doi: 10.1021/jm9003126.

引用本文的文献

1
Quantitative Characterization of Three Carbonic Anhydrase Inhibitors by LESA Mass Spectrometry.利用 LESA 质谱技术对三种碳酸酐酶抑制剂进行定量分析。
J Am Soc Mass Spectrom. 2022 Jul 6;33(7):1168-1175. doi: 10.1021/jasms.2c00024. Epub 2022 Jun 8.
2
Response to Perspectives on the Classical Enzyme Carbonic Anhydrase and the Search for Inhibitors.对经典酶碳酸酐酶及抑制剂探索相关观点的回应
Biophys J. 2021 Jan 5;120(1):178-181. doi: 10.1016/j.bpj.2020.11.011. Epub 2020 Dec 8.
3
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.
靶向代谢和肿瘤微环境的碳酸酐酶抑制剂
Metabolites. 2020 Oct 14;10(10):412. doi: 10.3390/metabo10100412.
4
Studying biomolecular folding and binding using temperature-jump mass spectrometry.使用温度跃变质谱研究生物分子折叠和结合。
Nat Commun. 2020 Jan 28;11(1):566. doi: 10.1038/s41467-019-14179-x.
5
Probing the Fundamentals of Native Liquid Extraction Surface Analysis Mass Spectrometry of Proteins: Can Proteins Refold during Extraction?探究天然液相萃取表面分析质谱法在蛋白质分析中的基本原理:蛋白质在提取过程中能否重新折叠?
Anal Chem. 2019 Oct 1;91(19):12246-12254. doi: 10.1021/acs.analchem.9b02075. Epub 2019 Sep 19.
6
Nanoscale Ion Emitters in Native Mass Spectrometry for Measuring Ligand-Protein Binding Affinities.用于测量配体-蛋白质结合亲和力的原生质谱中的纳米级离子发射器
ACS Cent Sci. 2019 Feb 27;5(2):308-318. doi: 10.1021/acscentsci.8b00787. Epub 2019 Jan 14.
7
Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.碳酸酐酶作为蛋白质及蛋白质-配体结合的生物物理和物理有机研究模型。
Chem Rev. 2008 Mar;108(3):946-1051. doi: 10.1021/cr050262p.
8
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity.与“双叉”抑制剂复合的人碳酸酐酶I和II的超高分辨率晶体结构揭示了高亲和力的分子基础。
J Am Chem Soc. 2006 Mar 8;128(9):3011-8. doi: 10.1021/ja057257n.
9
Clinical pharmacokinetics of dorzolamide.多佐胺的临床药代动力学
Clin Pharmacokinet. 2002;41(3):197-205. doi: 10.2165/00003088-200241030-00004.